5 Demands From the AHA to HHS on Recent 340B Ruling

The district court recently remanded remedy decisions to HHS for its underpayments related to the 340B drug pricing program.

After experiencing several key wins throughout their long legal battle with HHS, the American Hospital Association (AHA) and other industry plaintiffs were disappointed by the January ruling where a district court judged remanded HHS the question of how to repay 340B hospitals.

According to the AHA, this decision caused the repayments to be even further delayed—and a recent letter penned by the group outlines five ways the group says HHS can expediate the administrative process and avoid further legal challenges.

In the letter, the AHA calls for HHS to:

1. Repay each 340B hospital the full amount that was...

Today's Sponsors

Today's Sponsor